The battle between global drug makers and the Indian government shows no sign of abating as an industry trade group is urging the Obama administration to keep India on its annual list of countries that fail to protect and enforce patent rights.
Specifically, the pharmaceutical industry wants India to remain on what is known as the priority watch list of countries singled out for practices that are both favorable and unfavorable to American companies. The list is maintained by the US Trade Representative and updated in a report each spring (this is the 2015 report).
Read Full Article »